Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeljko Reiner

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of Hypertension|June 28, 2019
Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV RegistryRenata Cífková, Věra Lánská, Jan Bruthans, et al.
Pharmacological Research|July 28, 2022
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert PanelMaciej Banach, Alberico L Catapano, Arrigo F G Cicero, et al.
European Journal of Preventive Cardiology|April 20, 2012
Population-level changes to promote cardiovascular healthTorben Jørgensen, Simon Capewell, Eva Prescott, et al.
Atherosclerosis|April 24, 2021
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task ForceMaurizio Averna, Maciej Banach, Eric Bruckert, et al.
European Heart Journal|June 30, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Zeljko Reiner, Alberico L Catapano, et al.
European Heart Journal|October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G Nordestgaard, M John Chapman, Kausik Ray, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Global Heart|November 17, 2025
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!Maciej Banach, Zlatko Fras, Dan Gaita, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Hypertension|June 28, 2019
Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV RegistryRenata Cífková, Věra Lánská, Jan Bruthans, et al.
Pharmacological Research|July 28, 2022
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert PanelMaciej Banach, Alberico L Catapano, Arrigo F G Cicero, et al.
European Journal of Preventive Cardiology|April 20, 2012
Population-level changes to promote cardiovascular healthTorben Jørgensen, Simon Capewell, Eva Prescott, et al.
Atherosclerosis|April 24, 2021
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task ForceMaurizio Averna, Maciej Banach, Eric Bruckert, et al.
European Heart Journal|June 30, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Zeljko Reiner, Alberico L Catapano, et al.
European Heart Journal|October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G Nordestgaard, M John Chapman, Kausik Ray, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Global Heart|November 17, 2025
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!Maciej Banach, Zlatko Fras, Dan Gaita, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.
Pageof 10